Hypoparathyroidism associated with severe mineral bone disease postrenal transplantation, treated successfully with recombinant PTH

Hemodialysis International

Volumn 13, Issue 4, 2009, Pages 547-550

  Mahajan, Ashutosh ^a   Narayanan, Mohanram ^a   Jaffers, Gregory ^a   Concepcion, Luis ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

Author keywords

Chronic kidney disease; Hungry bone syndrome; Hypoparathyroidism; Renal transplantation; Teriparatide

Indexed keywords

CALCITRIOL; CALCIUM CARBONATE; PARATHYROID HORMONE[1-34]; PARICALCITOL; PHOSPHATE BINDING AGENT; PHOSPHORUS; RECOMBINANT HORMONE; VITAMIN D DERIVATIVE;

AGED; ARTICLE; BONE DISEASE; BONE METABOLISM; CASE REPORT; CHRONIC KIDNEY DISEASE; DIET; DISEASE SEVERITY; HUMAN; HYPERPHOSPHATEMIA; HYPOCALCEMIA; HYPOPARATHYROIDISM; KIDNEY TRANSPLANTATION; MALE; MINERAL METABOLISM; PARATHYROIDECTOMY; RENAL OSTEODYSTROPHY; SECONDARY HYPERPARATHYROIDISM;

AGED; CALCIUM; CREATININE; HUMANS; HYPERPARATHYROIDISM, SECONDARY; HYPOCALCEMIA; KIDNEY TRANSPLANTATION; MAGNESIUM; MALE; PARATHYROIDECTOMY; PHOSPHATES; RECOMBINANT PROTEINS; SYNDROME; TERIPARATIDE; TREATMENT OUTCOME;

EID: 70350527257     PISSN: 14927535     EISSN: 15424758     Source Type: Journal    
DOI: 10.1111/j.1542-4758.2009.00380.x     Document Type: Article

References (15)

1. Torregrosa NM, Rodríguez JM, Llorente S. Definitive treatment for persistent hypoparathyroidism in a kidney transplant patient. Thyroid 2005, 15:1299-1302.
2. Marx SJ. Hyperparathyroid and hypoparathyroid disorders. N Engl J Med 2000, 343:1863-1875.
3. Bieglmayer C, Prager G, Niederle B. Kinetic analyses of parathyroid hormone clearance as measured by three rapid immunoassays during parathyroidectomy. Clin Chem 2002, 48:1731-1738.
4. Feehally J, Floege J, Johnson RJ. Comprehensive Clinical Nephrology 2007, eds, 3rd ed, Philadelphia, PA, Mosby Elsevier
5. Farese S. The hungry bone syndrome-an update. Ther Umsch 2007, 64:277-280.
6. Miles AM, Markell MS, Sumrani N, Hong J, Friedman EA. Severe hyperparathyroidism associated with prolonged hungry bone syndrome in a renal transplant patient. J Am Soc Nephrol 1997, 8:1626-1631.
7. Schwarz A, Rustien G, Merkel S, Radermacher J, Haller H. Decreased renal transplant function after parathyroidectomy. Nephrol Dial Transplant 2007, 22:584-591.
8. Esbrit P, Santos S, Ortega A. Parathyroid hormone-related protein as a renal regulating factor. From vessels to glomeruli and tubular epithelium. Am J Nephrol 2001, 21:179-184.
9. Massfelder T, Parekh N, Endlich K. Effect of intrarenally infused parathyroid hormone-related protein on renal blood flow and glomerular filtration rate in the anaesthetized rat. Br J Pharmacol 1996, 118:1995-2000.
10. Jespersen B, Randløv A, Abrahamsen J, Fogh-Andersen N, Kanstrup IL. Effects of PTH(1-34) on blood pressure, renal function, and hormones in essential hypertension. Am J Hypertens 1997, 10((Part 1)):1356-1367.
11. http://www.fda.gov/cder/foi/label/2002/21318_forteo_lbl.pdf, Forteo. Available from, (accessed date: November 19, 2008)
12. Cejka D, Benesch T, Krestan C. Effect of teriparatide on early bone loss after kidney transplantation. Am J Transplant 2008, 8:1864-1870.
13. Puig-Domingo M, Díaz G, Nicolau J, Fernández C, Rueda S, Halperin I. Successful treatment of vitamin D unresponsive hypoparathyroidism with multi pulse subcutaneous infusion of teriparatide. Eur J Endocrinol 2008, 159:653-657.
14. Sanda S, Schlingmann KP, Newfield RS. Autosomal dominant hypoparathyroidism with severe hypomagnesemia and hypocalcemia, successfully treated with recombinant PTH and continuous subcutaneous magnesium infusion. J Pediatr Endocrinol Metab 2008, 21:385-391.
15. Winer KK, Sinaii N, Peterson D, Sainz B, Cutler GB. Effects of once versus twice-daily parathyroid hormone 1-34 therapy in children with hypoparathyroidism. J Clin Endocrinol Metab 2008, 93:3389-3395.